Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for Alopecia Areata
NCT02312882Completed
- Sponsor
- Stanford University
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tofacitinib oral solution in alopecia areata, sponsored by Stanford University. Primary endpoint: Percent Change in Severity of Alopecia Tool Score at 3 months. Started Dec 2014; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02312882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312882.